Abstract
Although adiponectin levels are associated with obesity and insulin insensitivity, the role of adiponectin in the progression to diabetes in non-obese subjects is unclear. Therefore, 289 women aged 50–80 years without previous history of diabetes or impaired glucose tolerance (IGT) were studied. They were classified as normal glucose tolerance (NGT), IGT or diabetes based on WHO criteria. Insulin sensitivity (S) and beta cell function (B) indices were calculated using homeostasis model assessment (HOMA). In obese women with BMI ≥ 25 kg/m2 (n = 161), there were declines in HOMA-%S (P < 0.001), HOMA-%B (P < 0.05) and circulating adiponectin (P < 0.001) across glucose tolerance status. In non-obese women with BMI < 25 kg/m2 (n = 128), there was no significant change in HOMA-%S in women with IGT and diabetes as compared to women with NGT. However, HOMA-%B (P < 0.05) and serum adiponectin levels (P < 0.001) were significantly decreased across glucose tolerance. Serum adiponectin levels were correlated to HOMA-%S in both obese and non-obese women while negative correlations between circulating adiponectin and HOMA-%B were demonstrated only in obese women. We have demonstrated in the present study the predominant role of beta cell dysfunction as compared to that of insulin resistance in the deterioration of glucose tolerance in non-obese women. Circulating adiponectin appears to be inversely related to beta cell dysfunction in addition to insulin resistance only in obese women.
Similar content being viewed by others
References
S. Lillioja, D.M. Mott, M. Spraul, R. Ferraro, J.E. Foley, E. Ravussin, W.C. Knowler, P.H. Bennett, C. Bogardus, Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N. Engl. J. Med. 329, 1988–1992 (1993)
R.A. Sicree, P.Z. Zimmet, H.O. King, J.S. Coventry, Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 yr. Diabetes 36, 179–186 (1987)
S. Lillioja, D.M. Mott, B.V. Howard, P.H. Bennett, H. Yki-Jarvinen, D. Freymond, et al., Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N. Engl. J. Med. 318, 1217–1225 (1988)
C. Weyer, P.A. Tataranni, C. Bogardus, R.E. Pratley, Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24, 89–94 (2001)
C. Weyer, C. Bogardus, D.M. Mott, R.E. Pratley, The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest. 104, 787–794 (1999)
B. Ludvik, J.J. Nolan, J. Baloga, D. Sacks, J. Olefsky, Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 44, 1121–1125 (1995)
K.H. Yoon, J.H. Lee, J.W. Kim, J.H. Cho, Y.H. Choi, S.H. Ko, P. Zimmet, H.Y. Son, Epidemic obesity and type 2 diabetes in Asia. Lancet 368, 1681–1688 (2006)
D.J. Kim, M.S. Lee, K.W. Kim, M.K. Lee, Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus. Metabolism 50, 590–593 (2001)
K. Matsumoto, S. Miyake, M. Yano, Y. Ueki, Y. Yamaguchi, S. Akazawa, et al., Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 20, 1562–1568 (1997)
M. Fukushima, M. Usami, M. Ikeda, Y. Nakai, A. Taniguchi, T. Matsuura, et al., Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism 53, 831–835 (2004)
N. Ouchi, S. Kihara, Y. Arita, Y. Okamoto, K. Maeda, H. Kuriyama, et al., Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102, 1296–1301 (2000)
W.S. Yang, C.Y. Jeng, T.J. Wu, S. Tanaka, T. Funahashi, Y. Matsuzawa, et al., Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 25, 376–380 (2002)
K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, Y. Okamoto, et al., Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20, 1595–1599 (2000)
C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley, et al., Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86, 1930–1935 (2001)
W.S. Yang, W.J. Lee, T. Funahashi, S. Tanaka, Y. Matsuzawa, C.L. Chao, C.L. Chen, T.Y. Tai, L.M. Chuang, Plasma adiponectin levels in overweight and obese Asians. Obes. Res. 10, 1104–1110 (2002)
World Health Organization, Obesity. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment, ed. by World Health Organization, Western Pacific Region (World Health Organization, Geneva, 2000)
American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 27(Suppl 1), S5–S10 (2004)
T.M. Wallace, J.C. Levy, D.R. Matthews, Use and abuse of HOMA modeling. Diabetes Care 27, 1487–1495 (2004)
C.C. Jensen, M. Cnop, R.L. Hull, W.Y. Fujimoto, S.E. Kahn, Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S Diabetes 51, 2170–2178 (2002)
Y. Yamamoto, H. Hirose, I. Saito, K. Nishikai, T. Saruta, Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J. Clin. Endocrinol. Metab. 89, 87–90 (2004)
R.S. Lindsay, T. Funahashi, R.L. Hanson, Y. Matsuzawa, S. Tanaka, P.A. Tataranni, et al., Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360, 57–58 (2002)
B.B. Duncan, M.I. Schmidt, J.S. Pankow, H. Bang, D. Couper, C.M. Ballantyne, et al., Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 53, 2473–2478 (2004)
F. Bacha, R. Saad, N. Gungor, S.A. Arslanian, Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 27, 547–552 (2004)
T.M. Wallace, J.C. Levy, D.R. Matthews, An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study. Diabet. Med. 21, 568–576 (2004)
E. Zeender, K. Maedler, D. Bosco, T. Berney, M.Y. Donath, P.A. Halban, Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta. J. Clin. Endocrinol. Metab. 89, 5059–5066 (2004)
Y. Miyazaki, A. Mahankali, E. Wajcberg, M. Bajaj, L.J. Mandarino, R.A. DeFronzo, Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 89, 4312–4319 (2004)
K. Maedler, P. Sergeev, F. Ris, J. Oberholzer, H.I. Joller-Jemelka, G.A. Spinas, et al., Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 110, 851–860 (2002)
R.H. Unger, Y.T. Zhou, Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 50(Suppl 1), S118–S121 (2001)
I. Rakatzi, H. Mueller, O. Ritzeler, N. Tennagels, J. Eckel, Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia 47, 249–258 (2004)
K. Staiger, N. Stefan, H. Staiger, M.D. Brendel, D. Brandhorst, R.G. Bretzel, F. Machicao, M. Kellerer, M. Stumvoll, A. Fritsche, Häring HU, Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis. J. Clin. Endocrinol. Metab. 90, 6707–6713 (2005)
Acknowledgement
This study was supported by the Thailand Research Fund.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chailurkit, Lo., Chanprasertyothin, S., Jongjaroenprasert, W. et al. Differences in insulin sensitivity, pancreatic beta cell function and circulating adiponectin across glucose tolerance status in Thai obese and non-obese women. Endocr 33, 84–89 (2008). https://doi.org/10.1007/s12020-008-9057-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-008-9057-y